{
    "code": "60000949",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000949",
    "time": "2023-11-24 16:09:20",
    "許可證字號": "衛部菌疫輸字第000949號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/11\/06",
    "發證\/登錄日期": "102\/11\/06",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000094906",
    "中文品名": "賀癌寧凍晶注射劑",
    "英文品名": "Kadcyla",
    "適應症": "乳癌：\r\n(1)轉移性乳癌：單獨使用時能夠治療HER2陽性、之前分別接受過\r\ntrastuzumab與一種taxane藥物治療或其合併療法的轉移性乳癌病人。\r\n說明：病人應符合下列條件：之前已經接受過轉移性癌症治療或在輔\r\n助療法治療期間或完成治療後6個月內癌症復發。\r\n(2)早期乳癌：單獨使用適用於HER2陽性早期乳癌病人，在接受過以\r\ntaxane和trastuzumab為基礎的前導性治療(neoadjuvant therapy)後，\r\n仍有殘留病灶的輔助療法(adjuvant therapy)。",
    "劑型": "243凍晶注射劑",
    "包裝": "100支以下盒裝 小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "107\/11\/06",
    "主成分略述": "Trastuzumab Emtansine",
    "限制項目": "02輸　入",
    "申請商名稱": "羅氏大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號40樓、40樓之1、41樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "F. HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "成品及包裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "LONZA LTD.",
            "製造廠廠址": "LONZASTRASSE, 3930 VISP, SWITERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "Roche Singapore Technical Operations Pte.Ltd.",
            "製造廠廠址": "10 Tuas Bay Link, 637394 Singapore",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "單株抗體製造廠"
        },
        {
            "製造廠名稱": "Lonza Biologics Tuas Pte Ltd.",
            "製造廠廠址": "35 Tuas South Avenue 6, Singapore, 637377",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "單株抗體製造廠"
        },
        {
            "製造廠名稱": "GENENTECH, INC.",
            "製造廠廠址": "1000 NEW HORIZONS WAY, VACAVILLE, CA 95688, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "單株抗體製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000510",
            "成分名稱": "Trastuzumab Emtansine",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Kadcyla 160mg_vial-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000949&Seq=008&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Kadcyla_CDS 10.0_0322-KAD-01 (450x500mm)_排-111-04-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000949&Seq=015&Type=9"
        },
        {
            "title": "5.2.1.2 中文化包裝_外盒_Kadcyla_160mg-109-03-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000949&Seq=028&Type=8"
        },
        {
            "title": "5.2.1.1 中文化包裝_外盒_Kadcyla_100mg-109-03-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000949&Seq=027&Type=8"
        },
        {
            "title": "5.3.1.2 中文化包裝_標籤_Kadcyla_160mg-109-03-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000949&Seq=026&Type=8"
        },
        {
            "title": "5.3.1.1 中文化包裝_標籤_Kadcyla_100mg-109-03-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000949&Seq=025&Type=8"
        }
    ]
}